Discover the history of EnzyTag


The history behind EnzyTag

EnzyTag was founded in December 2018 as a spin-out of EnzyPep. EnzyTag is a private investment and venture capital-backed company located in Geleen, in the south of The Netherlands adjacent to the Chemelot campus.

EnzyTag has a fully exclusive, world-wide, perpetual license to EnzyPep’s proprietary peptiligase technology for developing manufacturing processes for peptide-based new chemical entities (NCEs) and (bio)conjugates. The technology provides traceless and completely stereo- and regioselective ligation of peptides to other peptides, peptide-linked payloads and proteins.

Characteristics of peptiligase technology

  • Traceless
  • Aqueous conditions at near neutral pH

  • Regio- and stereoselective
  • No side reactions & Improved purity

  • Reduced synthesis lead time

  • Efficient scaling to commercial scale
  • Reduced synthesis lead time

  • Lower COGS and higher volumetric productivity

Please feel free to contact us

EnzyTag is open to further discussions on technology licensing for commercial purposes.

We use cookies to ensure that our website runs as smoothly as possible and to analyze web traffic. If you continue to use the website, you agree with our Privacy Policy. I agree